[Translation] A randomized, double-blind, placebo-controlled, single-dose, dose-escalation Phase I clinical study to evaluate the safety, pharmacokinetics and immunogenicity of HLX6018 in healthy subjects
主要研究目的:评估不同剂量HLX6018在健康受试者中的安全性和耐受性。
次要研究目的:评估HLX6018在健康受试者中的PK特征;评估HLX6018在健康受试者中的免疫原性。
[Translation] Primary study purpose: To evaluate the safety and tolerability of different doses of HLX6018 in healthy subjects.
Secondary study objectives: To evaluate the PK characteristics of HLX6018 in healthy subjects; to evaluate the immunogenicity of HLX6018 in healthy subjects.